|
Volumn 7, Issue 12, 2015, Pages 1535-1542
|
Targeting autophagy to overcome drug resistance in cancer therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 (4 HYDROXYPHENYL) 4 MORPHOLINOPYRIDO[3',2':4,5]FURO[3,2 D]PYRIMIDINE;
2 MORPHOLINO 8 PHENYLCHROMONE;
3 METHYLADENINE;
AMIODARONE;
ANTINEOPLASTIC AGENT;
AUTOPHAGY PROTEIN 5;
AZD 8055;
BECLIN 1;
CHLOROQUINE;
ENDOPHILIN;
ENDOPHILIN B1;
MICRORNA;
NICLOSAMIDE;
NOCODAZOLE;
PACLITAXEL;
PERHEXILINE;
PROTEIN;
PROTEIN P53;
QUINOLINE DERIVATIVE;
SAPANISERTIB;
SULFACETAMIDE;
SULFATHIAZOLE;
TETRAHYDROCANNABINOL;
UNCLASSIFIED DRUG;
UV RADIATION RESISTANCE ASSOCIATED GENE PROTEIN;
VISTUSERTIB;
WORTMANNIN;
PHOSPHATIDYLINOSITOL 3 KINASE;
PROTEIN KINASE B;
TARGET OF RAPAMYCIN KINASE;
AUTOPHAGY;
CANCER CHEMOTHERAPY;
CANCER RESISTANCE;
CELL ELONGATION;
CELL FUSION;
CELLULAR PARAMETERS;
DRUG EFFECT;
DRUG TARGETING;
HUMAN;
INDUCTION CHEMOTHERAPY;
MOLECULAR DOCKING;
NEOPLASM;
NONHUMAN;
ONCOGENE;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
REGULATORY MECHANISM;
REVIEW;
TREATMENT RESPONSE;
UNINDEXED SEQUENCE;
VESICLE ELONGATION;
VESICLE NUCLEATION;
ANIMAL;
DRUG DEVELOPMENT;
DRUG EFFECTS;
DRUG RESISTANCE;
METABOLISM;
MOLECULARLY TARGETED THERAPY;
NEOPLASMS;
PATHOLOGY;
PROCEDURES;
SIGNAL TRANSDUCTION;
ANIMALS;
ANTINEOPLASTIC AGENTS;
AUTOPHAGY;
DRUG DISCOVERY;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
MOLECULAR TARGETED THERAPY;
NEOPLASMS;
PHOSPHATIDYLINOSITOL 3-KINASES;
PROTO-ONCOGENE PROTEINS C-AKT;
SIGNAL TRANSDUCTION;
TOR SERINE-THREONINE KINASES;
|
EID: 84940909495
PISSN: 17568919
EISSN: 17568927
Source Type: Journal
DOI: 10.4155/fmc.15.88 Document Type: Review |
Times cited : (123)
|
References (19)
|